Search results
Results from the WOW.Com Content Network
Tablets of Truvada, a tenofovir/emtricitabine combination used for HIV pre-exposure prophylaxis. Pre-exposure prophylaxis for HIV prevention, commonly known as PrEP, is the use of antiviral drugs as a strategy for the prevention of HIV/AIDS by people that do not yet have HIV/AIDS. [1]
Ready, Set, PrEP is a program of the U.S. Department of Health and Human Services (HHS) that provides free access to the HIV prevention medication PrEP for thousands of qualifying individuals. The program is a key component of Ending the HIV Epidemic: A Plan for America (EHE) initiative to expand access to PrEP and reduce new HIV diagnoses in ...
But the Supreme Court may soon stop requiring insurers to cover PrEP and other preventive medical care services for free, pending the results of a case regarding the Affordable Care Act it's set ...
Medicaid covers healthcare costs for people with low incomes, while Medicare is a universal program providing health coverage for the elderly. Medicaid offers elder care benefits not normally covered by Medicare, including nursing home care and personal care services. There are also dual health plans for people who have both Medicaid and ...
The plaintiffs have argued that the PrEP requirement forces business owners to pay for services that "encourage homosexual behavior, prostitution, sexual promiscuity and intravenous drug use ...
Pre-exposure prophylaxis (PrEP), is the use of medications to prevent the spread of disease in people who have not yet been exposed to a disease-causing agent. Vaccination is the most commonly used form of pre-exposure prophylaxis ; other forms of pre-exposure prophylaxis generally involve drug treatment, known as chemoprophylaxis .
Discover the latest breaking news in the U.S. and around the world — politics, weather, entertainment, lifestyle, finance, sports and much more.
With insurance coverage, those uninsured or with governmental health insurance, such as Medicaid or Medicare through the Affordable Care Act (ACA), have minimal options for testing and treatment, more specifically, antiretroviral therapy (ART) and pre-exposure prophylaxis (PrEP), respectively. [57]